Ticker Details
XOMA Corporation XOMA Corp is a biotechnology company. It discovers and develops human and humanized monoclonal antibody-based therapeutics.
IPO Date:	July 1, 1986
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$710.16M
Activated in VL:	False

Average Daily Range
Avg Daily Range:	$0.35 | 3.47%
Avg Daily Range (30 D):	$2.86 | 6.40%
Avg Daily Range (90 D):	$0.46 | 1.10%

Institutional Daily Volume
Avg Daily Volume:	.93M
Avg Daily Volume (30 D):	.17M
Avg Daily Volume (90 D):	.19M

Trade Size
Avg Trade Size (Sh.):	400
Avg Trade Size (Sh.) (30 D):	194
Avg Trade Size (Sh.) (90 D):	94

Institutional Trades
Total Institutional Trades:	495
Avg Institutional Trade:	$1.73M
Avg Institutional Trade (30 D):	$3.21M
Avg Institutional Trade (90 D):	$2.1M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.63M
Avg Closing Trade (30 D):	$30.89M
Avg Closing Trade (90 D):	$3.47M
Avg Closing Volume:	73.66K

News

Jun 12, 2026 @ 8:05 PM XOMA Royalty Corporation Declares Quarterly Prefer... Source: Globe Newswire

May 14, 2026 @ 5:51 PM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve... Source: Brodsky & Smith

May 7, 2026 @ 1:14 AM Halper Sadeh LLC is Investigating Whether HLX, OGN... Source: Halper Sadeh Llc

Apr 28, 2026 @ 9:40 PM XOMA Investors Have the Opportunity to Join Invest... Source: Schall Law Firm

Apr 28, 2026 @ 1:23 AM Halper Sadeh LLC is Investigating Whether OGN, XOM... Source: Halper Sadeh Llc

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$1.65	$.18	$.27
Diluted EPS	$1.57	$.17	$.26
Revenue	$48.56M	$12.32M	$13.76M
Gross Profit
Net Income / Loss	$33.81M	$4.47M	$6.1M
Operating Income / Loss	$4.98M	$-.48M	$2.18M
Cost of Revenue
Net Cash Flow	$43.72M	$5.03M	$3.16M
PE Ratio